These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1321 related items for PubMed ID: 25843714

  • 1. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M, Kim T, Johnson RL, Lim DS.
    Cell Rep; 2015 Apr 14; 11(2):270-82. PubMed ID: 25843714
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC, Moroishi T, Meng Z, Jeong HS, Plouffe SW, Sekido Y, Han J, Park HW, Guan KL.
    Nat Cell Biol; 2017 Jul 28; 19(8):996-1002. PubMed ID: 28752853
    [Abstract] [Full Text] [Related]

  • 6. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
    Janse van Rensburg HJ, Azad T, Ling M, Hao Y, Snetsinger B, Khanal P, Minassian LM, Graham CH, Rauh MJ, Yang X.
    Cancer Res; 2018 Mar 15; 78(6):1457-1470. PubMed ID: 29339539
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O, Baek MJ, Wooldrik C, Johnson KR, Fisher KW, Lou J, Ricks TJ, Wen T, Best MD, Cryns VL, Anderson RA, Choi S.
    EMBO J; 2024 May 15; 43(9):1740-1769. PubMed ID: 38565949
    [Abstract] [Full Text] [Related]

  • 9. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ, Bronner SM, Zbieg JR.
    Expert Opin Ther Pat; 2018 Dec 15; 28(12):867-873. PubMed ID: 30482112
    [Abstract] [Full Text] [Related]

  • 10. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK, Jain M, Walla B, Johnsen M, Bartram MP, Huynh Anh M, Rinschen MM, Benzing T, Schermer B.
    J Biol Chem; 2016 May 27; 291(22):11596-607. PubMed ID: 27048650
    [Abstract] [Full Text] [Related]

  • 11. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L, Teng L.
    Int J Oncol; 2015 Apr 27; 46(4):1444-52. PubMed ID: 25652178
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways.
    Santinon G, Pocaterra A, Dupont S.
    Trends Cell Biol; 2016 Apr 27; 26(4):289-299. PubMed ID: 26750334
    [Abstract] [Full Text] [Related]

  • 14. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D, Guan KL.
    Genes Dev; 2015 Jun 15; 29(12):1271-84. PubMed ID: 26109050
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
    Plouffe SW, Lin KC, Moore JL, Tan FE, Ma S, Ye Z, Qiu Y, Ren B, Guan KL.
    J Biol Chem; 2018 Jul 13; 293(28):11230-11240. PubMed ID: 29802201
    [Abstract] [Full Text] [Related]

  • 18. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati O, Trisciuoglio D, Del Bufalo D, Di Martile M, Di Napoli A, Ruco L, Costantini S, Jakopin Z, Budillon A, Melino G, Del Sal G, Ciliberto G, Mancini R.
    Oncogene; 2017 Aug 10; 36(32):4573-4584. PubMed ID: 28368399
    [Abstract] [Full Text] [Related]

  • 19. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J, Wu T, Lin Q.
    Mol Biol Rep; 2023 May 10; 50(5):4565-4578. PubMed ID: 36877351
    [Abstract] [Full Text] [Related]

  • 20. The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.
    Lavado A, Park JY, Paré J, Finkelstein D, Pan H, Xu B, Fan Y, Kumar RP, Neale G, Kwak YD, McKinnon PJ, Johnson RL, Cao X.
    Dev Cell; 2018 Dec 03; 47(5):576-591.e8. PubMed ID: 30523785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.